Jun 03, 2019 / 11:00PM GMT
Pascal Soriot - AstraZeneca PLC - CEO & Executive Director
All right. Good evening, everybody. Welcome. Great pleasure to have you all here. As always, it's a very exciting time to be in Chicago for the ASCO. So this is -- sorry, this is -- well, this was our safe harbor statement, and it's really a pleasure to present tonight.
I will do the introduction with José. I will cover the -- I will cover a quick update, and José will cover an update of what we presented at ASCO and the news in our pipeline. But importantly, we want to engage you in those breakout discussions and hear your questions and spend much time as possible addressing your questions and comments you may have. So we are going to spend only about 20 minutes upfront and the rest of the time in the breakout.
So this is the agenda. As I said, I'm going to give you a quick update, and José will cover a pipeline update. We have some drinks and a little bit of food at the end.
So if we turn to Slide 5. This really is a slide that is reminding us all why we're here. There is -- there was in 2018 18 million new
AstraZeneca PLC at ASCO Annual Meeting Transcript
Jun 04, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers